Efficacy and safety of denosumab versus zoledronic acid in delaying skeletal-related events in patients with gastrointestinal cancer, pancreas-biliary system cancer, and other rare cancers.

Bibliographic Information

Title
Efficacy and safety of denosumab versus zoledronic acid in delaying skeletal-related events in patients with gastrointestinal cancer, pancreas-biliary system cancer, and other rare cancers.
Author
Imai H, Saijo K, Yamada H, Ohuchi K, Okada Y, Komine K, Takahashi M, Takahashi S, Takahashi M, Shimodaira H, Ishioka C.

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010282256826886403
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top